CF, H., YH, L., PC, T., ML, Y., CW, W., TY, J., . . . ML, Y. (2026). Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy. The Kaohsiung journal of medical sciences, e70214. https://doi.org/10.1002/kjm2.70214
Chicago Style (17th ed.) CitationCF, Huang, et al. "Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy." The Kaohsiung Journal of Medical Sciences 2026: e70214. https://doi.org/10.1002/kjm2.70214.
MLA (9th ed.) CitationCF, Huang, et al. "Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy." The Kaohsiung Journal of Medical Sciences, 2026, p. e70214, https://doi.org/10.1002/kjm2.70214.